Shubha Bhat, PharmD, MS, BCACP

home / authors / shubha-bhat-pharmd-ms-bcacp

Articles

Etrasimod: A New Oral Treatment Option for Ulcerative Colitis

December 6th 2023

The S1PR modulators are currently positioned to serve as a great treatment option for patients with moderate disease who are hesitant to escalate to a biologic treatment.

Risankizumab: A New Treatment Option for Crohn’s Disease

Shubha Bhat, PharmD, MS, BCACP

October 19th 2022

Risankizumab represents the first ever IL-23 treatment for adult patients with Crohn's disease approved by the FDA.

Gursimran Kochhar, MD | Credit: Allegheny Health Network

Published: October 4th 2024 | Updated: October 14th 2024

Minimally Invasive Techniques to Manage Complex Polyps at Allegheny Health Network

Published: May 2nd 2024 | Updated: May 6th 2024

Cardiology Month in Review: April 2024

Published: November 19th 2024 | Updated: November 22nd 2024

Laura Hamant, MD: Standardized Algorithm Increases VTE Prophylaxis Among Children

Published: October 9th 2014 | Updated: November 22nd 2024

Widespread "Yellow Bumps"

Published: November 18th 2024 | Updated: November 22nd 2024

The Medical Sisterhood: Role Models and Mentorship, with Susan Taylor, MD, and Linda Stein Gold, MD

Published: November 16th 2024 | Updated: November 22nd 2024

John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study

About Us

Advertise

Editorial

Do Not Sell My Information

Privacy

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Shubha Bhat, PharmD, MS, BCACP

Articles

Latest Updated Articles